X-linked Retinitis Pigmentosa

Stephen H Tsang; Tarun Sharma

doi:10.1007/978-3-319-95046-4_8

X-linked Retinitis Pigmentosa

Adv Exp Med Biol. 2018:1085:31-35. doi: 10.1007/978-3-319-95046-4_8.

Authors

Stephen H Tsang^{1

2}, Tarun Sharma³

Affiliations

¹ Jonas Children's Vision Care, Bernard & Shirlee Brown Glaucoma Laboratory, Columbia Stem Cell Initiative-Departments of Ophthalmology, Biomedical Engineering, Pathology & Cell Biology, Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
² Department of Ophthalmology, Columbia University, Edward S. Harkness Eye Institute, NewYork-Presbyterian Hospital, New York, NY, USA.
³ Department of Ophthalmology, Columbia University, Edward S. Harkness Eye Institute, NewYork-Presbyterian Hospital, New York, NY, USA. ts3118@cumc.columbia.edu.

PMID: 30578481
DOI: 10.1007/978-3-319-95046-4_8

Abstract

X-linked retinitis pigmentosa (XLRP) is considered to be one of the most severe forms of retinitis pigmentosa (RP). It accounts for about 6-20% of all RP cases, including about 10% in the United States and 25% in England.

Keywords: Retinitis pigmentosa; X-linked.

Publication types

Review

MeSH terms

Genetic Diseases, X-Linked / physiopathology*
Humans
Retinitis Pigmentosa / physiopathology*